摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-cyclobutyl-4-methyl-1,4-dihydroquinazolin-2-amine | 1005469-97-5

中文名称
——
中文别名
——
英文名称
N-cyclobutyl-4-methyl-1,4-dihydroquinazolin-2-amine
英文别名
——
N-cyclobutyl-4-methyl-1,4-dihydroquinazolin-2-amine化学式
CAS
1005469-97-5
化学式
C13H17N3
mdl
——
分子量
215.298
InChiKey
IAOSQRYQTIULAL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.46
  • 拓扑面积:
    36.4
  • 氢给体数:
    2
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    参考文献:
    名称:
    Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: Optimising brain penetration
    摘要:
    The optimisation of molecular properties within a series of 2-amino dihydroquinazoline 5-HT5A/5-HT7 receptor ligands resulted in a significantly improved brain-to-plasma ratio, enhancing the pharmacological utility of these compounds. By modulating the lipophilicity and pK(a), 20-fold increase in brain-to-plasma ratio could be achieved, leading to micromolar brain concentrations after oral administration. The enantiomers of one representative of this series of improved compounds were separated, and the configuration of the eutomer was determined by X-ray crystallography. (C) 2067 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2007.10.078
点击查看最新优质反应信息

文献信息

  • Cyclic guanidines as dual 5-HT5A/5-HT7 receptor ligands: Optimising brain penetration
    作者:Jens-Uwe Peters、Thomas Lübbers、Alexander Alanine、Sabine Kolczewski、Francesca Blasco、Lucinda Steward
    DOI:10.1016/j.bmcl.2007.10.078
    日期:2008.1
    The optimisation of molecular properties within a series of 2-amino dihydroquinazoline 5-HT5A/5-HT7 receptor ligands resulted in a significantly improved brain-to-plasma ratio, enhancing the pharmacological utility of these compounds. By modulating the lipophilicity and pK(a), 20-fold increase in brain-to-plasma ratio could be achieved, leading to micromolar brain concentrations after oral administration. The enantiomers of one representative of this series of improved compounds were separated, and the configuration of the eutomer was determined by X-ray crystallography. (C) 2067 Elsevier Ltd. All rights reserved.
查看更多